483
TEI Biosciences, Inc.FDA 483 - TEI Biosciences, Inc. - November 12, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
TEI Biosciences, Inc. in Boston, MA, was inspected and cited for significant deficiencies in quality system procedures. Observations included inadequate process parameter monitoring, unvalidated manufacturing processes, insufficient environmental control, and incorrect product labeling with extended expiration dates. Additionally, the firm failed to submit multiple Medical Device Reports for serious injuries and malfunctions within the required 30-day period.
Open in Dashboard
ID · 6fbe531a-6aa5-43a6-a858-e69e76e1f5c0